Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brimonidine PS DDS for visual recovery after macula-off retinal detachment
2009-015586-31Phase 2Completed
- Sponsor
- Allergan
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of brimonidine in rhegmatogenous retinal detachment (RRD) (3 arms), sponsored by Allergan. Primary endpoint: Visual function efficacy. Started Mar 2010; status: completed.
02
Drugs
brimonidine
03
Conditions
rhegmatogenous retinal detachment (RRD)
Beyond the preview
Go deeper on 2009-015586-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015586-31.